Table of Contents
Chapter 1. Global Artificial Intelligence In Pathology Market Executive Summary
1.1. Global Artificial Intelligence In Pathology Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Offering
1.3.2. By Application
1.3.3. By Technology
1.3.4. By Indication
1.3.5. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Artificial Intelligence In Pathology Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Artificial Intelligence In Pathology Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Adoption of AI in Healthcare
3.1.2. Rising Prevalence of Chronic Diseases
3.1.3. Government Initiatives to Promote AI in Healthcare
3.2. Market Challenges
3.2.1. High Implementation Costs
3.2.2. Data Privacy and Security Concerns
3.3. Market Opportunities
3.3.1. Integration of AI in Various Bioinformatics Applications
3.3.2. Expansion in Emerging Markets
Chapter 4. Global Artificial Intelligence In Pathology Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Artificial Intelligence In Pathology Market Size & Forecasts by Offering 2022-2032
5.1. Segment Dashboard
5.2. Global Artificial Intelligence In Pathology Market: Offering Revenue Trend Analysis, 2022 & 2032 (USD Million)
5.2.1. Software
5.2.2. Services
Chapter 6. Global Artificial Intelligence In Pathology Market Size & Forecasts by Application 2022-2032
6.1. Segment Dashboard
6.2. Global Artificial Intelligence In Pathology Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Million)
6.2.1. Drug Discovery
6.2.2. Disease Diagnosis & Prognosis
6.2.3. Clinical Workflow
6.2.4. Others
Chapter 7. Global Artificial Intelligence In Pathology Market Size & Forecasts by Technology 2022-2032
7.1. Segment Dashboard
7.2. Global Artificial Intelligence In Pathology Market: Technology Revenue Trend Analysis, 2022 & 2032 (USD Million)
7.2.1. Machine Learning
7.2.2. Deep Learning
7.2.3. Image Recognition
7.2.4. Natural Language Processing
7.2.5. Predictive Analytics
Chapter 8. Global Artificial Intelligence In Pathology Market Size & Forecasts by Indication 2022-2032
8.1. Segment Dashboard
8.2. Global Artificial Intelligence In Pathology Market: Indication Revenue Trend Analysis, 2022 & 2032 (USD Million)
8.2.1. Cancer
8.2.2. Infectious Disease
8.2.3. Autoimmune & Inflammatory Disease
8.2.4. Neurology Disorders
8.2.5. Others
Chapter 9. Global Artificial Intelligence In Pathology Market Size & Forecasts by End User 2022-2032
9.1. Segment Dashboard
9.2. Global Artificial Intelligence In Pathology Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Million)
9.2.1. Pharmaceutical & Biotechnology Companies
9.2.2. Hospitals & Diagnostic Centers
9.2.3. Academic & Research Institutes
9.2.4. Others
Chapter 10. Global Artificial Intelligence In Pathology Market Size & Forecasts by Region 2022-2032
10.1. North America Artificial Intelligence In Pathology Market
10.1.1. U.S. Artificial Intelligence In Pathology Market
10.1.1.1. Application breakdown size & forecasts, 2022-2032
10.1.1.2. Technology breakdown size & forecasts, 2022-2032
10.1.2. Canada Artificial Intelligence In Pathology Market
10.2. Europe Artificial Intelligence In Pathology Market
10.2.1. U.K. Artificial Intelligence In Pathology Market
10.2.2. Germany Artificial Intelligence In Pathology Market
10.2.3. France Artificial Intelligence In Pathology Market
10.2.4. Spain Artificial Intelligence In Pathology Market
10.2.5. Italy Artificial Intelligence In Pathology Market
10.2.6. Rest of Europe Artificial Intelligence In Pathology Market
10.3. Asia-Pacific Artificial Intelligence In Pathology Market
10.3.1. China Artificial Intelligence In Pathology Market
10.3.2. India Artificial Intelligence In Pathology Market
10.3.3. Japan Artificial Intelligence In Pathology Market
10.3.4. Australia Artificial Intelligence In Pathology Market
10.3.5. South Korea Artificial Intelligence In Pathology Market
10.3.6. Rest of Asia Pacific Artificial Intelligence In Pathology Market
10.4. Latin America Artificial Intelligence In Pathology Market
10.4.1. Brazil Artificial Intelligence In Pathology Market
10.4.2. Mexico Artificial Intelligence In Pathology Market
10.4.3. Rest of Latin America Artificial Intelligence In Pathology Market
10.5. Middle East & Africa Artificial Intelligence In Pathology Market
10.5.1. Saudi Arabia Artificial Intelligence In Pathology Market
10.5.2. South Africa Artificial Intelligence In Pathology Market
10.5.3. Rest of Middle East & Africa Artificial Intelligence In Pathology Market
Chapter 11. Competitive Intelligence
11.1. Key Company SWOT Analysis
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. Arterys
11.3.1.1. Key Information
11.3.1.2. Overview
11.3.1.3. Financial (Subject to Data Availability)
11.3.1.4. Product Summary
11.3.1.5. Market Strategies
11.3.2. Invicro
11.3.3. Siemens Healthcare
11.3.4. NVIDIA
11.3.5. 3DHISTECH
11.3.6. AI Medical Service Inc.
11.3.7. General Electric
11.3.8. Inspirata
11.3.9. Roche
11.3.10. IBM
11.3.11. Visage Imaging
11.3.12. Koninklijke Philips N.V.
11.3.13. PathAI
11.3.14. GE Healthcare
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes